215 related articles for article (PubMed ID: 9314945)
1. Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients.
Dingemans AM; Brakenhoff RH; Postmus PE; Giaccone G
Lab Invest; 1997 Sep; 77(3):213-20. PubMed ID: 9314945
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
3. Application of quantitative RT-PCR using "TaqMan" technology to evaluate the expression of CK 18 mRNA in various cell lines.
Tokunaga E; Maehara Y; Oki E; Koga T; Kakeji Y; Sugimachi K
J Exp Clin Cancer Res; 2000 Sep; 19(3):375-81. PubMed ID: 11144532
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
[TBL] [Abstract][Full Text] [Related]
5. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
[TBL] [Abstract][Full Text] [Related]
6. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
7. Detection of cancer cells in peripheral blood of breast cancer patients using reverse transcription-polymerase chain reaction for epidermal growth factor receptor.
Leitzel K; Lieu B; Curley E; Smith J; Chinchilli V; Rychlik W; Lipton A
Clin Cancer Res; 1998 Dec; 4(12):3037-43. PubMed ID: 9865918
[TBL] [Abstract][Full Text] [Related]
8. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
Fishman A; Klein A; Zemer R; Zimlichman S; Bernheim J; Cohen I; Altaras MM
Gynecol Oncol; 2000 Jun; 77(3):399-404. PubMed ID: 10831349
[TBL] [Abstract][Full Text] [Related]
9. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
10. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
11. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating cancer cells by nested reverse transcription-polymerase chain reaction of cytokeratin-19 (K19)--possible clinical significance in advanced gastric cancer.
Yeh KH; Chen YC; Yeh SH; Chen CP; Lin JT; Cheng AL
Anticancer Res; 1998; 18(2B):1283-6. PubMed ID: 9615802
[TBL] [Abstract][Full Text] [Related]
14. Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.
Masuda TA; Kataoka A; Ohno S; Murakami S; Mimori K; Utsunomiya T; Inoue H; Tsutsui S; Kinoshita J; Masuda N; Moriyama N; Mori M
Int J Oncol; 2005 Mar; 26(3):721-30. PubMed ID: 15703829
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.
Nakamura T; Yasumura T; Hayashi K; Eguchi R; Ide H; Takasaki K; Kasajima T
Anticancer Res; 2000; 20(6C):4739-44. PubMed ID: 11205210
[TBL] [Abstract][Full Text] [Related]
17. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.
Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G
Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating tumor cells in carcinoma patients by a novel epidermal growth factor receptor reverse transcription-PCR assay.
De Luca A; Pignata S; Casamassimi A; D'Antonio A; Gridelli C; Rossi A; Cremona F; Parisi V; De Matteis A; Normanno N
Clin Cancer Res; 2000 Apr; 6(4):1439-44. PubMed ID: 10778975
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR.
Fellowes VS; Husebekk A; Gress RE; Vance BA
Int J Oncol; 2004 Apr; 24(4):861-7. PubMed ID: 15010823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
